High 2-HG in IDH1 MT tumors increases the consumption of NADPH and limits the availability of NADPH for de novo lipogenesis11,12, raising the possibility that such tumor cells could be selectively vulnerable to FASN inhibition in IDH1 MT tumors. The gene discussed is IDH1; the disease is neoplasm.